When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...

Alnylam is rapidly transitioning from a high-burn clinical biotech into a highly profitable, self-sustaining commercial powerhouse. While Alnylam has done well in treating rare orphan diseases, its ...

If you like the idea of Brave's browser security, but all of the other features just get in your way, the developers have ...

Phasmophobia's cursed objects can be helpful to your investigation, but using them comes with risks. Here's where each spawns ...

Natera NTRA recently announced a partnership with Aveta Biomics to support AVTA 30-01, a global Phase 3 registrational trial ...

The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant. The U.S. Food and Drug Administration (FDA) has approved ...

A researcher found that using Anthropic’s Claude Opus 4.7, he could break into the website of Front Gate—used by every ...

Most people don't throw away old electronics --they relocate them. The laptop goes from the desk to the closet, the closet to ...

Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus standard-of-care docetaxel chemotherapy in patie ...

Natera and Aveta Biomics have entered into a strategic partnership to support the latter’s AVTA 30-01, a global Phase III ...

The decision affirms a lower court’s ruling nullifying Jimmie “Chris” Duncan’s 1998 first-degree murder conviction. Duncan ...